Vaginal Complaints

The list of types of vaginal discomfort is long, and they occur frequently. In this blog post, we would like to briefly explain one typical type of discomfort, vaginal atrophy, and its consequences.
Philip Schmiedhofer, MSc

Autor

Philip Schmiedhofer, MSc

Inhaltsverzeichnis

What is vaginal atrophy (vaginal dystrophy)?

Vaginal atrophy refers to a shrinking of the vaginal wall to a thinner and smoother surface with reduced functionality.

What are the causes of vaginal thinning?

The deeper cause is usually the natural drop in estrogen after the last menstrual bleeding (menopause), which leads to vulvovaginal thinning in all women after menopause.

Hormonal change as a trigger?

Since the described symptoms are caused by the natural decline of hormone levels during the change of life, potentially every woman in this stage of life is affected.

How do I recognize vaginal dryness?

The diagnosis is made by the women's doctor. Other illnesses that cause similar symptoms must definitely be ruled out. These include fungal infections and various sexually transmitted diseases.

What are the consequences of vaginal thinning?

The pH value of the vagina changes to a less acidic range of 6.0 to 8.0, and there is a shift in the vaginal flora towards more coliform bacteria.

What is vaginal atrophy (vaginal dystrophy)?

Vaginal atrophy refers to the thinning and smoothing of the vaginal wall with reduced functionality.

What causes vaginal atrophy?

The underlying cause is usually the natural drop in estrogen after the last menstrual period (menopause), which leads to vulvovaginal atrophy in all women after menopause, with typical symptoms such as vaginal dryness and pain during intercourse (dyspareunia). Estrogens are mainly produced in the ovaries and are important for maintaining blood flow, moisture (fluidity), and tissue elasticity in the vagina.

Hormonal changes as a trigger?

Since the described symptoms are caused by the natural decline in hormone levels during menopause , potentially every woman in this life stage is affected.
As estrogen levels drop in postmenopause, the vaginal epithelium smooths out, and the vaginal surface lacks glycogen, which serves as a nutrient base for lactobacilli important for a healthy vaginal flora. Vaginal fluid decreases during menopause, leading to vaginal dryness. Dryness in the vagina manifests as burning, itching, and pain during intercourse. Vaginal dryness is a risk factor for infections, and problems with the urinary system, such as bladder infections, can also occur.

Causes of vaginal dryness include, besides vaginal atrophy, medications, breastfeeding, as well as surgical and therapeutic procedures. Smoking and excessive intimate hygiene can also lead to vaginal dryness .

Another large group of women who may be affected by vulvovaginal atrophy are patients treated for breast cancer. Therapeutic treatments such as radiation therapy often have vaginal dryness as a side effect.

Vaginal dryness

How do I recognize vaginal dryness?

The diagnosis is made by a gynecologist. Other diseases that cause similar symptoms must be definitely ruled out. These include fungal infections and various sexually transmitted diseases, such as chlamydia infection or trichomoniasis.

Depending on the cause, treatment may include hormones, moisturizers, and agents to strengthen the vaginal environment. CANNEFF VAG SUP suppositories are also an effective treatment for vaginal dryness, vaginal discomfort, and pain during intercourse.

What are the consequences of vaginal atrophy?

The vaginal pH shifts to a less acidic range of 6.0 to 8.0, and the vaginal flora changes toward more coliform bacteria. Together with other atrophic changes, the altered pH combined with reduced regenerative capacity leads to increased susceptibility and frequency of infections and injuries. Additionally, bleeding and pain during intercourse (dyspareunia) occur.

Quellenverzeichnis anzeigen

Philip Schmiedhofer, MSc

Philip Schmiedhofer, MSc

Philip is the managing director and co-founder of cannhelp GmbH. With a degree in medical engineering and molecular biology, specializing in neuroscience and focusing on cannabinoids, he is recognized as an expert in the application of cannabinoids in medicine. As a medical device consultant, he also leads the sales of cannmedic and offers specialized advice for medical professionals. His expertise includes the development and sales of cannabinoid-based products. In the field of research, he participates in significant basic research at the Center for Brain Research at the Medical University of Vienna. As co-founder and current managing director of cannmedic GmbH, a pioneer in the CBD medical products market, he has many years of entrepreneurial experience. Additionally, he maintains an extensive network in the industry and advises internationally operating companies in the field of medical cannabinoids.